Normal liver tissue sparing by intensity-modulated proton stereotactic body radiotherapy for solitary liver tumours

References

• Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M. Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies. Br J Cancer 2006;94:982–99.
   PubMed Web of Science ®Google Scholar
• Hoyer M, Roed H, Traberg HA, Ohlhuis L, Petersen J, Nellemann H, . Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol 2006;45: 823–30.
   PubMed Web of Science ®Google Scholar
• Lax I, Blomgren H, Naslund I, Svanstrom R. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 1994;33:677–83.
   PubMed Web of Science ®Google Scholar
• Dawson LA, Ten Haken RK. Partial volume tolerance of the liver to radiation 1. Semin Radiat Oncol 2005;15:279–83.
   PubMed Web of Science ®Google Scholar
• Dawson LA, Eccles C, Craig T. Individualized image guided iso-NTCP based liver cancer SBRT. Acta Oncol 2006;45: 856–64.
   PubMed Web of Science ®Google Scholar
• Mendez RA, Wunderink W, Hussain SM, de Pooter JA, Heijmen BJ, Nowak PC, . Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase I-II study. Acta Oncol 2006;45:831–7.
   PubMed Web of Science ®Google Scholar
• Pan CC, Kavanagh BD, Dawson LA, Li XA, Das SK, Miften M, . Radiation-associated liver injury. Int J Radiat Oncol Biol Phys 2010;76(3 Suppl):S94–100.
   Web of Science ®Google Scholar
• Lo SS, Fakiris AJ, Teh BS, Cardenes HR, Henderson MA, Forquer JA, . Stereotactic body radiation therapy for oligometastases. Expert Rev Anticancer Ther 2009;9:621–35.
   PubMed Web of Science ®Google Scholar
• Rusthoven KE, Kavanagh BD, Cardenes H, Stieber VW, Burri SH, Feigenberg SJ, . Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 2009;27:1572–8.
   PubMed Web of Science ®Google Scholar
• Tse RV, Hawkins M, Lockwood G, Kim JJ, Cummings B, Knox J, . Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol 2008;26:657–64.
   PubMed Web of Science ®Google Scholar
• Wong SL, Mangu PB, Choti MA, Crocenzi TS, Dodd GD, III, Dorfman GS, . American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol 2010;28:493–508.
   PubMed Web of Science ®Google Scholar
• McCammon R, Schefter TE, Gaspar LE, Zaemisch R, Gravdahl D, Kavanagh B. Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2009;73: 112–8.
   PubMed Web of Science ®Google Scholar
• Lassen-Ramshad Y, Vestergaard A, Muren A, Petersen J. Plan robustness in proton beam therapy of a childhood brain tumour. Acta Oncol 2011 (in press).
   PubMed Web of Science ®Google Scholar
• Worm ES, Hansen AT, Petersen JB, Muren LP, Praestegaard LH, Hoyer M. Inter- and intrafractional localisation errors in cone-beam CT guided stereotactic radiation therapy of tumours in the liver and lung. Acta Oncol 2010;49:1177–83.
   PubMed Web of Science ®Google Scholar
• Dawson LA, Normolle D, Balter JM, McGinn CJ, Lawrence TS, Ten Haken RK. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 2002;53:810–21.
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Constine LS, Deasy JO, Eisbruch A, Jackson A, Marks LB, . Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): An introduction to the scientific issues. Int J Radiat Oncol Biol Phys 2010; 76(3 Suppl):S3–9.
   PubMed Web of Science ®Google Scholar
• Wang X, Krishnan S, Zhang X, Dong L, Briere T, Crane CH, . Proton radiotherapy for liver tumors: Dosimetric advantages over photon plans. Med Dosim 2008;33:259–67.
   PubMed Web of Science ®Google Scholar
• Bush DA, Kayali Z, Grove R, Slater JD. The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: A phase 2 prospective trial. Cancer Epub 2011 Jan 24.
   Google Scholar
• Kawashima M, Furuse J, Nishio T, Konishi M, Ishii H, Kinoshita T, . Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma. J Clin Oncol 2005;23:1839–46.
   PubMed Web of Science ®Google Scholar
• Nakayama H, Sugahara S, Tokita M, Fukuda K, Mizumoto M, Abei M, . Proton beam therapy for hepatocellular carcinoma: The University of Tsukuba experience. Cancer 2009;115:5499–506.
   PubMed Web of Science ®Google Scholar
• Sugahara S, Oshiro Y, Nakayama H, Fukuda K, Mizumoto M, Abei M, . Proton beam therapy for large hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2010;76: 460–6.
   PubMed Web of Science ®Google Scholar
• Sugahara S, Nakayama H, Fukuda K, Mizumoto M, Tokita M, Abei M, . Proton-beam therapy for hepatocellular carcinoma associated with portal vein tumor thrombosis. Strahlenther Onkol 2009;185:782–8.
   PubMed Web of Science ®Google Scholar